[ad_1]
ADMA Biologics ADMA reported its Q2 earnings results on Wednesday, August 10, 2022 at 04:00 PM.
Here’s what investors need to know about the announcement.
Earnings
ADMA Biologics beat estimated earnings by 12.5%, reporting an EPS of $-0.07 versus an estimate of $-0.08.
Revenue was up $16.07 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.02 which was followed by a 17.48% increase in the share price the next day.
Here’s a look at ADMA Biologics’s past performance:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.08 | -0.09 | -0.14 | -0.15 |
| EPS Actual | -0.10 | -0.09 | -0.13 | -0.14 |
| Revenue Estimate | 27.69M | 21.76M | 18.72M | 16.42M |
| Revenue Actual | 29.10M | 26.38M | 20.68M | 17.83M |
To track all earnings releases for ADMA Biologics visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
[ad_2]
Image and article originally from www.benzinga.com. Read the original article here.